-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since the end of 2019, coronavirus disease 2019 ( COVID-19 ), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally, affecting people all over the world
Figure: Impact of multidrug-resistant Acinetobacter baumannii infection on outcomes of COVID-19 patients hospitalized in the intensive care unit
The results of this study demonstrate the prognostic impact of BSI in patients with COVID-19, that Acinetobacter baumannii colonization and steroid use are associated with an increased risk of MDR-AB infection during COVID-19
Original source:
Alessandro Russo.
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.
Leave a comment here